TriSalus Life Sciences (TLSI) Short Interest Ratio & Short Volume

Short interest is the volume of TriSalus Life Sciences shares that have been sold short but have not yet been closed out or covered. As of April 15th, investors have sold 26,400 shares of TLSI short. 0.20% of TriSalus Life Sciences' shares are currently sold short. Learn More on TriSalus Life Sciences' current short interest.

Companies that have a short interest as a percentage of float below 10% indicates positive investor sentiment and few short sellers. Stocks with a short interest percentage above 10% is considered high, suggesting some investors are pessimistic about the stock. Companies with a short interest percentage of 20% or more indicates widespread negative sentiment. 0.20% of TriSalus Life Sciences' floating shares are currently sold short.

TriSalus Life Sciences saw a drop in short interest in the month of April. As of April 15th, there was short interest totaling 26,400 shares, a drop of 78.5% from the previous total of 123,000 shares. Changes in short volume can be used to identify positive and negative investor sentiment. Investors that short sell a stock are betting that its price will decline in the future. An increase in short sale volume suggests bearish (negative) sentiment among investors. A decrease on short sale volume suggests bullish (positive) sentiment.

TriSalus Life Sciences currently has issued a total of 32,272,000 shares. Some of TriSalus Life Sciences' outstanding shares are available for trading, while others are subject to various restrictions. The public float, also referred to as floating shares or "the float", are shares that publicly owned, unrestricted and available to trade on the open market. TriSalus Life Sciences currently has a public float of 13,430,000 shares.

0.20% of TriSalus Life Sciences' shares are currently sold short. Here is how the short interest of companies in the industry of "medical equipment" compare to TriSalus Life Sciences: AxoGen, Inc. (4.72%), Iradimed Corporation (2.58%), Embecta Corp. (4.22%), RxSight, Inc. (9.51%), SI-BONE, Inc. (3.75%), Avanos Medical, Inc. (2.08%), Butterfly Network, Inc. (7.67%), OrthoPediatrics Corp. (6.79%), Treace Medical Concepts, Inc. (4.97%), Delcath Systems, Inc. (3.96%),

As of the most recent reporting period, the following stocks had the largest short interest positions: Invesco QQQ ($21.71 billion), iShares 20+ Year Treasury Bond ETF ($9.48 billion), Strategy Incorporated ($8.92 billion), Charter Communications, Inc. ($3.86 billion), Apollo Global Management, Inc. ($3.86 billion), Capital One Financial Co. ($3.72 billion), Super Micro Computer, Inc. ($3.47 billion), AppLovin Co. ($2.64 billion), VanEck Semiconductor ETF ($2.46 billion), and The Kroger Co. ($2.33 billion). View all of the most shorted stocks.

Short selling TLSI is an investing strategy that aims to generate trading profit from TriSalus Life Sciences as its price is falling. TLSI shares are trading down $0.04 today. To short a stock, an investor borrows shares, sells them and buys the shares back on the public market later to return it to the lender. Short sellers are betting that a stock will decline in price. If the stock does drop after selling, the short seller buys it back at a lower price and returns it to the lender. The difference between the sell price and the buy price is the trader's profit.

A short squeeze for TriSalus Life Sciences occurs when it has a large amount of short interest and its stock appreciates in price. This forces short sellers to cover their short interest positions by buying actual shares of TLSI, which in turn drives the price of the stock up even further.

Short interest is typically published by a stock exchange once per month. However, NASDAQ publishes a report for U.S. stocks, including TLSI, twice per month. The most recent reporting period available is April, 15 2025.